Inhibitory effect of hexamethylene bisacetamide on replication of human cytomegalovirus

Archives of Virology

Volumn 150, Issue 10, 2005, Pages 1977-1991

  Kitagawa, R ^a   Hagihara, K ^a   Uhara, M ^a   Matsutani, K ^a   Kirita, A ^a   Tanaka, J ^a  

^a KANAZAWA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACETAMIDE DERIVATIVE; ANTIVIRUS AGENT; GANCICLOVIR; HEXAMETHYLENEBISACETAMIDE; IE1 PROTEIN, CYTOMEGALOVIRUS; IE2 PROTEIN, CYTOMEGALOVIRUS; IMMEDIATE EARLY PROTEIN; TRANSACTIVATOR PROTEIN; VIRUS ANTIGEN; VIRUS PROTEIN;

ARTICLE; BIOSYNTHESIS; CELL DIVISION; CELL LINE; COMPARATIVE STUDY; CYTOMEGALOVIRUS; DRUG EFFECT; HUMAN; IMMUNOLOGY; PHYSIOLOGY; VIRUS REPLICATION;

ACETAMIDES; ANTIGENS, VIRAL; ANTIVIRAL AGENTS; CELL DIVISION; CELL LINE; CYTOMEGALOVIRUS; GANCICLOVIR; HUMANS; IMMEDIATE-EARLY PROTEINS; TRANS-ACTIVATORS; VIRAL PROTEINS; VIRUS REPLICATION;

HUMAN HERPESVIRUS 5;

EID: 25444494782     PISSN: 03048608     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00705-005-0556-3     Document Type: Article

References (51)

1. PW Andrews E Gonczol SA Plotkin M Dignazio JW Oosterhuis 1986 Differentiation of TERA-2 human embryonal carcinoma cells into neurons and HCMV permissive cells. Differentiation 31 119 126
2. F Baldanti M Bloeckh S Chou C Crumpacker S Danner WL Drew D Emanuel A Erice WD Hardy S Spector 1996 Drug resistance in cytomegalovirus: current knowledge and implication for patient management. J Acquir Immune Defic Syndr Hum Retrovirol 12 [Suppl 1] S1 S22
3. F Baldanti E Silini A Sarasini CL Talarico SC Stanat KK Biron M Furione F Bono G Palu G Gerna 1995 A three-nucleotide deletion in the UL97 open reading frame is responsible for the ganciclovir resistance of a human cytomegalovirus clinical isolate. J Virol 69 796 800
4. F Baldanti L Simnoncini CL Talarico A Sarasini KK Biron G Gerna 1988 Emergence of a ganciclovir-resistant human cytomegalovirus strain with a new UL97 mutation in an AIDS patient. AIDS 12 816 818
5. DL Bernstein JC Kappes 1988 Enhanced in vitro reactivation of herpes simplex virus from neural and peripheral tissues with hexamethylenebisactamide. Arch Viro 99 57 65
6. Britt WJ, Alford CA (1996) Cytomegalovirus. In: Fields BN (ed) Fields virology. Lippincott-Raven, Philadelphia, pp 2493-2523
7. JH Bruning CA Bruggeman CP van Boven PJ van Breda Vriesman 1986 Passive transfer of cytomegalovirus by cardiac and renal organ transplants in a rat model. Transplantation 41 695 698
8. J Chambers A Angulo D Amaratunga H Guo Y Jiang JS Wan A Bittner K Frueh MR Jackson PA Peterson MG Erlander P Ghazal 1999 DNA microarays of the complex human cytomegalovirus genome. J Virol 73 5757 5766
9. KS Cheung DJ Lang 1977 Transmission and activation of cytomegalovirus with blood transfusion: A mouse model. J Infect Dis 135 841 845
10. S Chou S Guentzel KR Michels RC Miner WL Drew 1995 Frequency of UL97 phosphotransferase mutations related to ganciclovir resistance in clinical cytomegalovirus isolates. J Infect Dis 172 239 242
11. E De Clercq 1993 Therapeutic potential of HPMPC as an antiviral drug. Rev Med Virol 3 85 96
12. TM) for the treatment of DMA virus (i.e. herpes-, papova-, pox-, and adenovirus) infections. Verh K Acad Geneesk Belg 58 19 49
13. JN Dowling BC Wu JA Armstrong M Ho 1977 Enhancement of murine cytomegalovirus infection during graft-vs.- host reaction. J Infect Dis 135 990 994
14. A Erice S Chou KK Biron SC Stanat HH Balfour Jr MC Jordan 1989 Progressive disease due to ganciclovir-resistant cytomegalovirus in immunocompromised patients. N Eng J Med 320 289 293
15. G Fayet T Amphoux-Fazekas A Aouani S Hovsepian 1996 Hexamethylenebis- acetamide (HMBA) is a growth factor for human, ovine and porcine thyroid cells. Mol Cell Endocrinol 117 111 116
16. EA Fortunato DH Spector 1999 Regulation of human cytomegalovirus gene expression. Adv Virus Res 54 61 128
17. JM Gawn RF Greaves 2002 Absence of IE1 p72 protein function during low multiplicity infection by human cytomegalovirus results in a broad block to viral delayed-early gene expression. J Virol 76 4441 4455
18. RF Greaves ES Mocarski 1998 Defective growth correlates with reduced accumulation of a viral DNA replication protein after low-multiplicity infection by a human cytomegalovirus ie1 mutant. J Virol 72 366 379
19. YS He L Xu ES Huang 1992 Characterization of human cytomegalovirus UL84 early gene and identification of its putative protein product. J Virol 66 1098 1108
20. RW Johnstone E Cretney MJ Smyth 1999 P-glycoprotein protects leukemia cells against caspase-dependent, but not caspase-independent, cell death. Blood 93 1075 1085
21. Y Kondo Y Yura H Iga T Yanagawa H Yoshida N Furumoto M Sato 1990 Effect of hexamethylene bisacetamide and cyclosporine A on recovery of herpes simplex virus type 2 from the in vitro model of latency in a human neuroblastoma cell Line. Cancer Res 50 7852 7857
22. OL Laskin CM Stahl-Bayliss CM Kalman LR Rosecan 1987 Use of ganciclovir to treat serious cytomegalovirus infections in patients with AIDS. J Infect Dis 155 323 327
23. DA Leib DM Coen CL Bogard KA Hicks DR Yager DM Knipe KL Tyler PA Schaffer 1989 Immediate-early regulatory gene mutants define different stages in the establishment and reactivation of herpes simplex virus latency. J Virol 63 759 768
24. NS Lurain LE Spafford KD Thompson 1994 Mutation in the open reading flame of human cytomegalovirus strains resistant to ganciclovir. J Virol 68 4427 4431
25. EC Mar YC Cheng ES Huang 1983 Effect of 9-(1,3-dihydroxy-2-propoxymethyl) guanine on human cytomegalovirus replication in vitro. Antimicrob Agents Chemother 24 518 521
26. A Marchini H Liu H Zhu 2001 Human cytomegalovirus with IE-2 (UL122) deleted fails to express early lytic genes. J Virol 75 1870 1878
27. MC Mazeron G Jahn B Plachter 1992 Monoclonal antibody E-13 (McAb 810) to human cytomegalovirus recognizes an epitope encoded by exon 2 of the major immediate early gene. J Gen Virol 73 2699 2703
28. M McFarlane JI Daksis CM Preston 1992 Hexamethylene bisacetamide stimulates herpes simplex virus immediate early gene expression in the absence of trans-induction by Vmw65. J Gen Virol 73 285 292
29. JL Meier MF Stinski 1996 Regulation of human cytomegalovirus immediate-early gene expression. Intervirology 39 331 342
30. JD Meyers 1988 Prevention and treatment of cytomegalovirus infection after marrow transplantation. Bone Marrow Transplant 3 95 104
31. Mocarski ES, Courcelle CT (2001) Cytomegalovirus and their replication. In: Knipe DM, Howley PM (eds) Fields virology. Lippincott Williams and Wilkins, Philadelphia, pp 2629-2673
32. ES Mocarski GW Kemble JM Lyle RF Greaves 1996 A deletion mutant in the human cytomegalovirus gene encoding IE1 491aa is replication defective due to a failure in autoregulation. Proc Natl Acad Sci USA 93 11321 11326
33. Mocarski ES (1996) Cytomegalovirus and their replication. In: Fields BN, Knipe DM, Howley PM, Chanock RM, Melnick JL, Monath TP, Roizman B, Straus SE (eds) Fields virology. Lippincott-Raven, Philadelphia, pp 2447-2492
34. JA Nelson JW Gnann Jr P Ghazal 1990 Regulation and tissue-specific expression of human cytomegalovirus. Curr Top Microbiol Immunol 154 75 100
35. Oberg B, Behrnetz S, Eriksson B, Jozwiak H, Larsson A, Lernestedt JD, Aberg VL (1988) Clinical use of foscarnet (phosphonoformate). In: De Clercq E (ed) Clinical use of antiviral drugs. Martinus Nijhoff, Boston, MA, pp 223-240
36. GS Pari MA Kacica DG Anders 1993 Open reading frames UL44, IRS1/TRS1, and UL36-38 are required for transient complementation of human cytomegalovirus oriLyt-dependent DNA synthesis. J Virol 67 2575 2582
37. CM Preston M McFarlane 1998 Cytodifferentiating agents affect the replication of herpes simplex virus type 1 in the absence functional VP16. Virology 249 418 426
38. VM Richon Y Webb R Merger T Sheppard B Jursic L Ngo F Givoli R Breslow RA Rifkind PA Marks 1996 Second generation hybrid polar compounds are potent inducers of transformed cell differentiation. Proc Natl Acad Sci USA 93 5705 5708
39. KE Schmader R Rahija KR Porter G Delay JD Hamilton 1992 Aging and activation of latent murine cytomegalovirus. J Infect Dis 166 1403 1407
40. Serody JS, van der Horst CM (1993) The control of cytomegalovirus infection: Chemotherapy. In: Becker Y, Darai G, Huang ES (eds) Molecular aspects of human cytomegalovirus diseases. Springer, Berlin Heidelberg New York Tokyo, pp 256-282
41. DR Singer TJ Fallon WE Schulenburg G Williams J Cohen 1985 Foscarnet for cytomegalovirus retinitis (letter). Ann Intern Med 109 962
42. YJ Song MF Stinski 2002 Effect of the human cytomegalovirus IE86 protein on expression of E2F-responsive genes: a DNA microarray analysis. Proc Natl Acad Sci USA 99 2836 2841
43. SC Stanat JI Reardon A Erice MC Jordan WL Drew KK Biron 1991 Ganciclovir-resistant cytomegalovirus clinical isolates: model of resistance to ganciclovir. Antimicrob Agents Chemother 35 2191 2197
44. J Tanaka T Ogura H Sato M Hatano 1987 Establishment and biological characterization of an in vitro human cytomegalovirus latency model. Virology 161 62 72
45. J Tanaka H Sadanari H Sato S Fukuda 1991 Sodium butyrate-inducible replication of human cytomegalovirus in a human epithelial cell line. Virology 185 271 280
46. SL Walmsley E Chew SE Read H Vellend I Salit A Rachlis MM Fanning 1988 Treatment of cytomegalovirus retinitis with trisodiumphosphonoformate hexahydrate (Foscarnet). J Infect Dis 157 569 572
47. KL Weiland NL Oien F Homa MW Wathen 1994 Functional analysis of human cytomegalovirus polymerase accessory protein. Virus Res 34 191 206
48. AJ Whitby WA Blyth TJ Hill 1987 The effect of DNA hypomethylating agents on the reactivation of herpes simplex virus from latently infected mouse ganglia in vitro. Arch Virol 97 137 144
49. K Yagyu M Takeshita T Otsuka H Kubota A Furuse PJ van Breda Vriesman 1994 Reactivation of latent cytomegalovirus in allografts: comparison of lung graft and kidney graft in rats. Transplant Proc 26 2343 2344
50. Y Yura Y Kondo H Iga K Harada H Tsujimoto T Yanagawa H Yoshida M Sato 1991 Enhanced replication of herpes simplex virus by hexamethylene bisacetamide. J Natl Cancer Inst 83 186 189
51. H Zhu JP Cong D Yu WA Bresnahan TE Shenk 2002 Inhibition of cyclooxygenase 2 blocks human cytomegalovirus replication. Proc Natl Acad Sci USA 99 3932 3937